Skip to main content

Advertisement

SpringerLink
Log in

Perioperative management of hepatectomy in patients with interstitial pneumonia: a report of three cases and a literature review

  • Review Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

Interstitial pneumonia (IP) is a progressive and irreversible fibrosis and can be fatal if acute exacerbation (AE) occurs. While a useful risk-scoring system has been established for lung surgery, no risk evaluation exists for AE of IP related to non-pulmonary surgery. The objective of this review is to describe the management for patients with IP.

Methods

We experienced three hepatectomy cases with IP. The first was a 72-year-old male patient diagnosed with hepatocellular carcinoma. Preoperative computed tomography (CT) revealed IP with reticular shadow at the base of both lungs. After hepatectomy, his IP became acutely exacerbated and did not improve with steroid or sivelestat treatment. The second was a 74-year-old male patient diagnosed with hepatocellular carcinoma, and the third was a 75-year-old male patient with liver metastasis. In both these cases, CT revealed a reticular shadow in the lung fields, with increased serum KL-6 levels. We administered pirfenidone for perioperative management, during which time no respiratory complications occurred.

Results

Perioperative management with pirfenidone for hepatectomy accompanied by IP was successful in our cases.

Conclusion

We reviewed reports on the perioperative prevention, intraoperative risk factors, and treatment of postoperative AE of IP and summarized the perioperative management techniques for IP patients undergoing non-pulmonary surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Nanashima A, Nagayasu T. Development and clinical usefulness of the liver hanging maneuver in various anatomical hepatectomy procedures. Surg Today. 2016;46:398–404.

    Article  PubMed  Google Scholar 

  2. Kawaguchi Y, Otsuka Y, Kaneko H, et al. Comparisons of financial and short-term outcomes between laparoscopic and open hepatectomy: benefits for patients and hospitals. Surg Today. 2016;46:535–42.

    Article  PubMed  Google Scholar 

  3. Chiyo M, Sekine Y, Iwata T, et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg. 2003;126:1141–6.

    Article  PubMed  Google Scholar 

  4. Kushibe K, Kawaguchi T, Takahama M, et al. Operative indications for lung cancer with idiopathic pulmonary fibrosis. Thorac Cardiovasc Surg. 2007;55:505–8.

    Article  CAS  PubMed  Google Scholar 

  5. Sato T, Kondo H, Watanabe A, et al. A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients. Gen Thorac Cardiovasc Surg. 2015;63:164–72.

    Article  PubMed  Google Scholar 

  6. Suzuki H, Sekine Y, Yoshida S, et al. Risk of acute exacerbation of interstitial pneumonia after pulmonary resection for lung cancer in patients with idiopathic pulmonary fibrosis based on preoperative high-resolution computed tomography. Surg Today. 2011;41:914–21.

    Article  PubMed  Google Scholar 

  7. Watanabe A, Higami T, Ohori S, et al. Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thorac Cardiovasc Surg. 2008;136:1357–63 (1363 e1351–1352).

    Google Scholar 

  8. Fujita J, Yamadori I, Namihira H, et al. Increased intensity of lung infiltrates at the side of lung cancer in patients with lung cancer associated with pulmonary fibrosis. Lung Cancer. 1999;26:169–74.

    Article  CAS  PubMed  Google Scholar 

  9. Choi SM, Lee J, Park YS, et al. Postoperative pulmonary complications after surgery in patients with interstitial lung disease. Respiration. 2014;87:287–93.

    Article  PubMed  Google Scholar 

  10. Katayama H, Kurokawa Y, Nakamura K, et al. Extended Clavien–Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46:668–85.

    Article  PubMed  Google Scholar 

  11. Kubota T, Miyata A. Postoperative respiratory failure caused by acute exacerbation of idiopathic interstitial pneumonia. J Anesth. 2011;25:422–5.

    Article  PubMed  Google Scholar 

  12. Ghatol A, Ruhl AP, Danoff SK. Exacerbations in idiopathic pulmonary fibrosis triggered by pulmonary and nonpulmonary surgery: a case series and comprehensive review of the literature. Lung. 2012;190:373–80.

    Article  PubMed  Google Scholar 

  13. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Iwata T, Yoshida S, Fujiwara T, et al. Effect of perioperative pirfenidone treatment in lung cancer patients with idiopathic pulmonary fibrosis. Ann Thorac Surg. 2016;102:1905–10.

    Article  PubMed  Google Scholar 

  15. Sato T, Teramukai S, Kondo H, et al.: Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg 2014;147:1604–11 (e1603).

    Google Scholar 

  16. Doyle IR, Nicholas TE, Bersten AD. Serum surfactant protein-A levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome. Am J Respir Crit Care Med. 1995;152:307–17.

    Article  CAS  PubMed  Google Scholar 

  17. Ohnishi H, Yokoyama A, Kondo K, et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med. 2002;165:378–81.

    Article  PubMed  Google Scholar 

  18. Iwata T, Yoshida S, Nagato K, et al. Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis. Surg Today. 2015;45:1263–70.

    Article  PubMed  Google Scholar 

  19. Ohshimo S, Ishikawa N, Horimasu Y, et al. Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis. Respir Med. 2014;108:1031–9.

    Article  PubMed  Google Scholar 

  20. King TE Jr, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083–92.

    Article  PubMed  Google Scholar 

  21. Taniguchi H, Ebina M, Kondoh Y, et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J. 2010;35:821–9.

    Article  CAS  PubMed  Google Scholar 

  22. Lancaster L, Albera C, Bradford WZ, et al. Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials. BMJ Open Respir Res. 2016;3:e000105.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Bonella F, Stowasser S, Wollin L. Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib. Drug Des Devel Ther. 2015;9:6407–19.

    PubMed  PubMed Central  Google Scholar 

  24. Azuma A, Furuta T, Enomoto T, et al. Preventive effect of erythromycin on experimental bleomycin-induced acute lung injury in rats. Thorax. 1998;53:186–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Li Y, Azuma A, Takahashi S, et al. Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice. Chest. 2002;122:2137–45.

    Article  CAS  PubMed  Google Scholar 

  26. Radomska-Lesniewska DM, Skopinska-Rozewska E, Jankowska-Steifer E, et al. N-Acetylcysteine inhibits IL-8 and MMP-9 release and ICAM-1 expression by bronchoalveolar cells from interstitial lung disease patients. Pharmacol Rep. 2010;62:131–8.

    Article  CAS  PubMed  Google Scholar 

  27. Demedts M, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 2005;353:2229–42.

    Article  CAS  PubMed  Google Scholar 

  28. Taooka Y, Maeda A, Hiyama K, et al. Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med. 1997;156:260–5.

    Article  CAS  PubMed  Google Scholar 

  29. Ito H, Nakayama H, Yokose T, Yamada K. Prophylaxis for acute exacerbation of interstitial pneumonia after lung resection. Asian Cardiovasc Thorac Ann. 2014;22:948–54.

    Article  CAS  PubMed  Google Scholar 

  30. Sakamoto S, Homma S, Mun M, et al. Acute exacerbation of idiopathic interstitial pneumonia following lung surgery in 3 of 68 consecutive patients: a retrospective study. Intern Med. 2011;50:77–85.

    Article  PubMed  Google Scholar 

  31. Mizuno Y, Iwata H, Shirahashi K, et al. The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer. Eur J Cardiothorac Surg. 2012;41:e161–5.

    Article  PubMed  Google Scholar 

  32. Panos RJ, Mortenson RL, Niccoli SA, King TE Jr. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med. 1990;88:396–404.

    Article  CAS  PubMed  Google Scholar 

  33. Sakamoto S, Homma S, Miyamoto A, et al. Cyclosporin A in the treatment of acute exacerbation of idiopathic pulmonary fibrosis. Intern Med. 2010;49:109–15.

    Article  CAS  PubMed  Google Scholar 

  34. Inase N, Sawada M, Ohtani Y, et al. Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid. Intern Med. 2003;42:565–70.

    Article  CAS  PubMed  Google Scholar 

  35. Ambrosini V, Cancellieri A, Chilosi M, et al. Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J. 2003;22:821–6.

    Article  CAS  PubMed  Google Scholar 

  36. Okamoto T, Gotoh M, Masuya D, et al. Clinical analysis of interstitial pneumonia after surgery for lung cancer. Jpn J Thorac Cardiovasc Surg. 2004;52:323–9.

    Article  PubMed  Google Scholar 

  37. Abe M, Tsushima K, Matsumura T, et al. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study. Drug Des Devel Ther. 2015;9:5755–62.

    PubMed  PubMed Central  Google Scholar 

  38. Kubo H, Nakayama K, Yanai M, et al. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest. 2005;128:1475–82.

    Article  CAS  PubMed  Google Scholar 

  39. Ikeda S, Sekine A, Baba T, et al. Administration of nintedanib after discontinuation for acute exacerbation of idiopathic pulmonary fibrosis: a case report. BMC Pulm Med. 2016;16:38.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Seo Y, Abe S, Kurahara M, et al. Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonary fibrosis. Intern Med. 2006;45:1033–8.

    Article  PubMed  Google Scholar 

  41. Abe S, Seo Y, Hayashi H, et al. Neutrophil adsorption by polymyxin B-immobilized fiber column for acute exacerbation in patients with interstitial pneumonia: a pilot study. Blood Purif. 2010;29:321–6.

    Article  CAS  PubMed  Google Scholar 

  42. Enomoto N, Suda T, Uto T, et al. Possible therapeutic effect of direct haemoperfusion with a polymyxin B immobilized fibre column (PMX-DHP) on pulmonary oxygenation in acute exacerbations of interstitial pneumonia. Respirology. 2008;13:452–60.

    Article  PubMed  Google Scholar 

  43. Oishi K, Mimura-Kimura Y, Miyasho T, et al. Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of idiopathic pulmonary fibrosis. Cytokine. 2013;61:84–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan

    Norio Kubo, Kenichiro Araki, Takahiro Yamanaka, Kouki Hoshino, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Akira Watanabe, Keitaro Hirai, Fumiyoshi Saitoh & Ken Shirabe

  2. Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, Japan

    Norio Kubo, Kenichiro Araki, Takahiro Yamanaka, Norihiro Ishii, Mariko Tsukagoshi, Akira Watanabe, Fumiyoshi Saitoh & Hiroyuki Kuwano

Authors
  1. Norio Kubo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenichiro Araki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takahiro Yamanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kouki Hoshino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Norihiro Ishii
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mariko Tsukagoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takamichi Igarashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Akira Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Keitaro Hirai
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Fumiyoshi Saitoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hiroyuki Kuwano
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Ken Shirabe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kenichiro Araki.

Ethics declarations

Conflict of interest

All authors have nothing to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kubo, N., Araki, K., Yamanaka, T. et al. Perioperative management of hepatectomy in patients with interstitial pneumonia: a report of three cases and a literature review. Surg Today 47, 1173–1179 (2017). https://doi.org/10.1007/s00595-017-1489-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-017-1489-7

Keywords

Search

Navigation